Electrospinning Stimuli-Responsive Fibers at the Nanoscale as Functional Drug Delivery Mats

134755-Thumbnail Image.png
Description
The objective of this research is to create biodegradable mats with tunable characteristics such as fiber diameter and surface area. The drug delivery mats enable spatially controlled delivery of disease-specific therapeutics. Using a large electric potential to draw fibers

The objective of this research is to create biodegradable mats with tunable characteristics such as fiber diameter and surface area. The drug delivery mats enable spatially controlled delivery of disease-specific therapeutics. Using a large electric potential to draw fibers from a solution flowing at a specific rate, the polymer fibers reach a grounded target several inches away. The biodegradable polymer used in this study was poly(lactic acid-co-glycolic acid) (PLGA). PLGA solutions ranging from 0.5 to 27 wt.% were prepared by dissolving the block copolymer in a solvent mixture containing tetrahydrofuran (THF) and dimethylformamide (DMF) at a 3:1 weight ratio. They were then electrospun at needle-to-target distances of 7, 14, and 18 cm and rates ranging from 0.8 to 4 mL/h. The range of voltage used was between 8 – 15 kV, which was based on the observation of the formation of a Taylor cone, largely affected by on the environment and weather (e.g., temperature and humidity in the lab). A 27 wt.% PLGA solution, electrospun at 1 mL/h at a voltage of 11.25 kV and needle-to-target distance of 14 cm produced uniform fibers with an average fiber diameter of 0.985 m. All other parameters outside the range given created beaded fibers. In addition, solution rheology was performed on some of the PLGA solution to measure viscosity, which is directly correlated to the fiber diameter of the electrospun mats. Observing the impact of solvent on fiber spinning and fiber diameter brings about many positive results in developing fully characterized and well-understood fibrous mats for drug delivery. The nanoscale fibers will be used as drug delivery mats and, therefore, the biodegradation kinetics of the polymers will be studied. Next, parameters of the polymers as well as the polymeric mats will be correlated to the degradation-mediated release of small molecule therapeutics (e.g., peptides, drugs, etc.) such that time-resolved dosing profiles can be created.
Date Created
2016-12
Agent